SHORTENING OF HOSPITAL STAY AND IMPROVING SURVIVAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Formulations containing a Vitamin D compound or analog, such as paricalcitol (Zemplar(TM)) are useful for shortening hospital stays in chronic kidney disease patients with or without hyperparathyroidism. Also disclosed are methods of shortening hospital stays for chronic kidney disease patients with...

Full description

Saved in:
Bibliographic Details
Main Authors AMDAHL, MICHAEL, J, MARX, STEVEN, E, MELNICK, JOEL, Z, MATHES, ANGELO, OSTROW, DAVID, H, WILLIAMS, LAURA, A, O'BRIEN, MARK, H
Format Patent
LanguageEnglish
French
German
Published 08.06.2005
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Formulations containing a Vitamin D compound or analog, such as paricalcitol (Zemplar(TM)) are useful for shortening hospital stays in chronic kidney disease patients with or without hyperparathyroidism. Also disclosed are methods of shortening hospital stays for chronic kidney disease patients with or without hyperparathyroidism, and methods for determining reduction length of hospital stay in chronic kidney disease patients with or without hyperparathyroidism. Titration to serum calcium or serum PTH is avoided by use of the invention.
Bibliography:Application Number: EP20030788596